Fundraising Fox
/Companies
Sign in

CardioSignal

Turku, FI · Founded 2016 · 33 employees on LinkedIn · 5 known investors

Find your way into CardioSignal

Each arrow is one introduction. Sign up to fill in the first one.

454 people can intro you to Ilkka

Ask Marko Kuisma to introduce you to Ilkka Korhonen

You →Marko · together at CardioSignal by Precordior →Ilkka

183 people can intro you to Juuso

Ask Jamie Chen to introduce you to Juuso Blomster

You →Jamie · together at Genomill →Juuso

19 people can intro you to Kristiina

Ask Sam Okafor to introduce you to Kristiina Santalahti

You →Sam · together at Turun yliopisto - University of Turku →Kristiina

Sign up to find every way you can get introduced to CardioSignal

  • Your email: who you already know at CardioSignal, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the CardioSignal team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.

AI & Machine LearningDigital HealthHealthtechMedical Devices

Founders & leadership

CardioSignal was founded in 2016 by Tuomas Valtonen.

TV
Tuomas ValtonenCOO, Co-founder
JBJuuso Blomster
Juuso BlomsterFounder, CEO
IKIlkka Korhonen
Ilkka KorhonenChief Technology OfficerIlkka Korhonen is an engineer and researcher with three decades of experience developing biosignal algorithms and sensor technologies for consumer wearables and regulated medical devices. He held roles including CTO at Firstbeat Technologies, co-founder and CTO of PulseOn, and has worked at Nokia, Meta, and GE Healthcare; he also held an academic position in ICT for health.
KS
Kristiina SantalahtiResearch & Quality DirectorKristiina Santalahti has spent five years in medical device startups, developing expertise in regulatory strategy and compliance for EU and US markets with a focus on software as a medical device and clinical evidence for regulatory approval. Her background includes a decade of academic research in cardiovascular epidemiology, biomarkers, and immunology.

Investors · 5

Innovestor Ventureslisted by Innovestor VenturesHelsinki · $270K – $3.2M

How we know: Innovestor Ventures's portfolio page · Not right? Tell us

Sandwaterlisted by SandwaterOslo · $2.2M – $11M

How we know: Sandwater's portfolio page · funding news · Not right? Tell us

Start Capitallisted by Start Capital
Maki.vcreportedHelsinki · $324K – $3.2M

How we know: funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$10M disclosed across 1 round · 2024

Source: company announcements and press reports — follow each round's link for the claim.

In the news

CardioSignal Raises $10 Million in Series A — CardioSignalcardiosignal.com · Jan 2024CardioSignal - Tech Company Profile - Gaebler.com Venture Capital Databasegaebler.com

Frequently asked questions

What does CardioSignal do?
CardioSignal develops digital cardiac biomarkers using motion sensors in smartphones to detect heart disease without additional devices, targeting patients and primary care systems globally. The technology replaces invasive and costly standard diagnostic methods to enable faster and more accessible cardiovascular care.
Who founded CardioSignal?
CardioSignal was founded by Tuomas Valtonen in 2016.
Who are CardioSignal's investors?
CardioSignal's investors include DigiTx Partners LLC, Innovestor Ventures, Sandwater, Start Capital, Maki.vc.
How much funding has CardioSignal raised?
CardioSignal has disclosed $10M raised across 1 round.
Where is CardioSignal headquartered?
CardioSignal is headquartered in Turku, FI.